London-based GSK is preparing to roll out its RSV vaccine in the U.S. and European Union this fall.
You are here: Home / GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
Market News and Views
London-based GSK is preparing to roll out its RSV vaccine in the U.S. and European Union this fall.